CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
The significance of Oncotype DX recurrence score in T1-2N1M0 ER positive HER2 negative breast cancer: An analysis combined with the prognostic stage in the updated AJCC 8th edition 会议论文
作者:  Zhang, M.;  Chen, H.;  Wang, M.;  Zhang, P.;  Wu, K.
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials 期刊论文
ONCOTARGETS AND THERAPY, 2017, 卷号: 10
作者:  Li, Cunfu;  Xiang, Aizhai;  Chen, Xianzhi;  Yin, Kai;  Lu, Jinsong
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 35
作者:  Gong, Chengcheng;  Zhao, Yannan;  Wang, Biyun;  Hu, Xichun;  Wang, Zhonghua
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Jin, Xi;  Jiang, Yi-Zhou;  Chen, Sheng;  Yu, Ke-Da;  Ma, Ding
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial 期刊论文
PLOS ONE, 2015, 卷号: 10, 期号: 7
作者:  Li, Ting;  Wang, Biyun;  Wang, Zhonghua;  Ragaz, Joseph;  Zhang, Jian
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/19
First-line chemotherapy versus first-line endocrine therapy in hormone receptor positive HER2 negative patients with metastatic breast cancer in China: Results of the study of breast cancer group of the Chinese Society of Clinical Oncology (CSCO) 会议论文
作者:  Wang, T.;  Yang, T. T.;  Yang, L. J.;  Song, H. Y.;  Ouyang, C. Q.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace